Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Harris

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Human Molecular Genetics|April 5, 2020
A genome-wide association study finds genetic variants associated with neck or shoulder pain in UK BiobankWeihua Meng, Brian W Chan, Cameron Harris, et al.
Cancer Immunology Research|February 7, 2020
B cell-Derived IL35 Drives STAT3-Dependent CD8<sup>+</sup> T-cell Exclusion in Pancreatic CancerBhalchandra Mirlekar, Daniel Michaud, Samuel J Lee, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled studyJim Christenson, Michael D Hill, Richard H Swartz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Human Molecular Genetics|April 5, 2020
A genome-wide association study finds genetic variants associated with neck or shoulder pain in UK BiobankWeihua Meng, Brian W Chan, Cameron Harris, et al.
Cancer Immunology Research|February 7, 2020
B cell-Derived IL35 Drives STAT3-Dependent CD8<sup>+</sup> T-cell Exclusion in Pancreatic CancerBhalchandra Mirlekar, Daniel Michaud, Samuel J Lee, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled studyJim Christenson, Michael D Hill, Richard H Swartz, et al.
Pageof 2